Trials / Completed
CompletedNCT02847481
A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
A Pilot Study to Evaluate Fecal Microbiota Transplantation Engraftment in Irritable Bowel Syndrome
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized pilot study to characterize engraftment of a donor's microflora onto patients with Irritable Bowel Syndrome with diarrhea following fecal microbiota transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | fecal microbiota transplantation | fecal microbiota transplantation |
| DRUG | placebo fecal microbiota transplantation | placebo fecal microbiota transplantation |
| PROCEDURE | FMT with antibiotic pre-treatment (v1) | FMT with antibiotic pre-treatment (v1) |
| PROCEDURE | FMT with antibiotic pre-treatment (v2) | FMT with antibiotic pre-treatment (v2) |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-08-05
- Completion
- 2018-08-05
- First posted
- 2016-07-28
- Last updated
- 2019-12-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02847481. Inclusion in this directory is not an endorsement.